The Effect of Aromatherapy with Rosa Damascene Mill on Apnea of Prematurity

The Clinical Trial Effect of Aromatherapy with Rosa Damascene Mill on Reducing The Apnea of Premature Neonates from 29 to 33 weeks

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2017071735149N1

Enrollment

Registered

2017-11-19

Start date

2017-11-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Apnea of Prematurity. other apnea of newborn

Interventions

Intervention 1: In interventional group use Rosa damascene mill 10% that has diluted with sweet almond oil 90%/ Newborns have conditions to come in study from second day of life or after cutting NCPAP

Treatment - Drugs

Placebo

In interventional group use Rosa damascene mill 10% that has diluted with sweet almond oil 90%/ Newborns have conditions to come in study from second day of life or after cutting NCPAP or NIPPV/ For 3

all of steps in control group use distilled water as placebo.

Eligibility

Sex/Gender

All

Age

1 Days to 10 Days

Inclusion criteria

Inclusion criteria: Inclusion criteria: Neonates with gestational age from 29 to 33 weeks; Weights of neonates from 900 to 1500 grams; Neonates into the incubator no warmer; Hemoglobin more than 10 milligram for deciliter; No congenital heart disease; No infection; Neonates do not intubate; Neonates after cutting nasal continuous positive airway pressure (NCPAP) or nasal intermittent positive pressure ventilation (NIPPV) during study. Exclusion criteria: Parents want to come out this study; Neonates releasing or expiring before end of intervention; Symptoms or signs of skin or respiratory allergy during this intervention; The neonates that they become was during this intervention or to be disagreement for any reason.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Number of apnea. Timepoint: From begining to end of intervention every hour. Method of measurement: Observation and recording respiratory- heart monitoring.;Blood o2 saturation. Timepoint: From begining to end of intervention. Method of measurement: Palseoximeteri.	—

Secondary

Measure	Time frame
Heart rate. Timepoint: From begining to end of intervention. Method of measurement: Heart monitoring.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Parvaneh Sadeghimoghadam

Qom University of Medical Sciences

psadeghi@muq.ac.ir; khabbazan_atefeh@yahoo.com+98 25 3271 1301

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026